Secondary Logo

Journal Logo

March 2020 - Volume 43 - Issue 3
pp: 149-228

ACR-ASTRO Practice Parameter

Health Policy


Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question—Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial

Abrams, Ross A.; Winter, Kathryn A.; Safran, Howard; More

American Journal of Clinical Oncology. 43(3):173-179, March 2020.

Experimental therapeutics

Analysis of Heterogeneity in Survival Benefit of Immunotherapy in Oncology According to Patient Demographics and Performance Status: A Systematic Review and Meta-Analysis of Overall Survival Data

Butaney, Mohit; Satkunasivam, Raj; Goldberg, Hanan; More

American Journal of Clinical Oncology. 43(3):193-202, March 2020.

Head and Neck


Definitive Local Therapy for Oligo-recurrence in Patients With Completely Resected Non–small Cell Lung Cancer

Matsuguma, Haruhisa; Nakahara, Rie; Wakamatsu, Ikuma; More

American Journal of Clinical Oncology. 43(3):210-217, March 2020.